Recap: Galmed Pharmaceuticals Q1 Earnings

Galmed Pharmaceuticals GLMD reported its Q1 earnings results on Thursday, June 1, 2023 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Galmed Pharmaceuticals beat estimated earnings by 27.33%, reporting an EPS of $-1.09 versus an estimate of $-1.5.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.6 which was followed by a 4.42% increase in the share price the next day.

To track all earnings releases for Galmed Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.